BVMF/BIOM3 (BVMF/BIOM3)

Brazil Stock Exchange: BVMF/BIOM3 · BRL

R$5.34

-0.18 (-3.3%)· Recorded snapshot

Market cap	730.8M
Revenue (ttm)	384.4M
Net income (ttm)	30.3M
EPS (ttm)	R$0.22
Shares out	136.9M
P/E (trailing)	24.1x
Volume	27,700
Beta	0.49

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 384.4M
Net income (ttm): 30.3M
EPS (ttm): R$0.22
P/E (trailing): 24.1x
Market cap: 730.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E24.1

P25 n/aP50 n/aP75 n/a

ROE10.8

P25 n/aP50 n/aP75 n/a

ROIC8.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/BIOM3 indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

BRL

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-13
Employees	130
Employees change	3
Employees growth	2.36%
Enterprise value	BRL 813.4M
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2001
Industry	Biotechnology
Is primary listing	Yes
ISIN number	BRBIOMACNOR2
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Market cap	BRL 730.8M
Next earnings date	2026-11-13
Price	BRL 5.34
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bvmf/BIOM3
Website	https://www.biomm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	4.15%
EV/Earnings	27.64x
EV/EBIT	20.75x
EV/EBITDA	16.59x
EV/Sales	2.18x
FCF / EV yield	-12.16%
FCF yield	-13.49%
Graham number	3.44065
Graham upside	-35.69%
P/B ratio	2.32x
P/E ratio	24.12x
P/S ratio	1.97x
Price / tangible book value	2.92x
Price/EBITDA ratio	15.08x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.5%
EBITDA margin	13.03%
Effective tax rate	15.38%
Gross margin	36.06%
Operating margin	10.51%
Pretax margin	9.32%
Profit margin	7.89%
Profit per employee	BRL 233,269
Profitable quarters	3
Revenue per employee	BRL 3M
ROA	4.89%
ROA (5Y)	-9.88%
ROCE	10.7%
ROE	10.77%
ROE (5Y)	-44.25%
ROIC	8.55%
ROIC (5Y)	-25.08%
SBC / revenue	0.06%
Tax / revenue	1.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-85.71%
EPS growth quarters	8
EPS growth years	3
Gross profit growth	699.25%
Gross profit growth (Q)	310.51%
Gross profit growth 3Y	93.53%
Gross profit growth 5Y	45.01%
Net income growth (QoQ)	-80.93%
Net income growth quarters	6
Net income growth years	3
Revenue growth	176.51%
Revenue growth (Q)	229.09%
Revenue growth (QoQ)	-3.27%
Revenue growth 3Y	46.56%
Revenue growth 5Y	34.88%
Revenue growth quarters	4
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -25.6M
Depreciation and amortization	BRL 9.7M
EBIT	BRL 40.4M
EBITDA	BRL 50.1M
EPS	BRL 0.22
FCF per share	BRL -0.74
Financing cash flow	BRL 41.8M
Free cash flow	BRL -101.9M
Free cash flow minus SBC	BRL -102.1M
Gross profit	BRL 138.6M
Income taxes	BRL 5.5M
Investing cash flow	BRL 28.6M
Net borrowing	BRL -15.1M
Net cash flow	BRL -6M
Net income	BRL 30.3M
Operating cash flow minus SBC	BRL -76.5M
Operating income	BRL 40.4M
Revenue	BRL 384.4M
Stock-based compensation	BRL 240,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.72
Book value per share	BRL 2.38
Debt / EBITDA	1.84
Debt / equity	0.29
Interest coverage	3.9
Long-term assets	BRL 247.7M
Long-term liabilities	BRL 52.4M
Net cash (debt)	BRL -82.6M
Net cash / market cap	-10.94%
Net debt / EBITDA	1.65
Net debt / equity	0.25
Piotroski F-Score	5
Property, plant and equipment	BRL 164.6M
Shareholders' equity	BRL 325.2M
Tangible book value	BRL 258.6M
Tangible book value per share	BRL 1.89
Total assets	BRL 614.9M
Total cash	BRL 10.4M
Total debt	BRL 93M
Total liabilities	BRL 289.7M
WACC	7.22%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.74
Current assets	BRL 367.2M
Current liabilities	BRL 237.4M
Current ratio	1.55
Inventory turnover	1.47
Net working capital	BRL 192M
Quick ratio	0.38
Working capital	BRL 129.9M
Working capital turnover	3.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.3%
Shareholder yield	-7.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-24.79%
10Y return CAGR	-1.75%
10Y total return	-16.18%
150-day SMA	BRL 6.63
15Y price change	154.29%
15Y return CAGR	7.19%
15Y total return	183.4%
1D price change	-3.26%
1M price change	-12.89%
1M total return	-12.89%
1W price change	-15.64%
1W total return	-15.64%
1Y price change	-37.54%
1Y return CAGR	-37.56%
1Y total return	-37.54%
20-day SMA	BRL 6.23
200-day SMA	BRL 6.63
20Y price change	90.71%
20Y return CAGR	4.52%
20Y total return	142.27%
3M price change	-9.8%
3M total return	-9.8%
3Y price change	14.59%
3Y return CAGR	6.69%
3Y total return	21.43%
50-day SMA	BRL 6.33
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 9.75
52-week high date	2025-12-05
52-week low	BRL 4.82
52-week low date	2026-07-31
5Y price change	-60.15%
5Y return CAGR	-15.71%
5Y total return	-57.46%
6M price change	-27.35%
6M total return	-27.35%
All-time high	BRL 29.00
All-time high date	2020-06-02
All-time low	BRL 0.42
All-time low date	2004-07-27
Average true range (ATR)	BRL 0.37
Average volume	81K
Beta (1Y)	0.16
Beta (2Y)	0.45
Beta (5Y)	0.49
Change from 52-week high	-45.23%
Change from 52-week low	10.79%
Change from all-time high	-81.59%
Change from all-time low	1,179.96%
Change from open	-4.81%
Day's gap	1.63%
Dollar volume	BRL 147,918
High price	BRL 5.61
Low price	BRL 5.31
Monthly RSI	41.31
Open price	BRL 5.61
Position in 52-week range	10%
Previous close	BRL 5.52
Price vs 150-day SMA	-19.42%
Price vs 20-day SMA	-14.24%
Price vs 200-day SMA	-19.43%
Price vs 50-day SMA	-15.65%
Relative volume	0.34
RSI	35.47
Sharpe ratio	-0.65
Sharpe ratio (3Y)	0.41
Sharpe ratio (5Y)	-0.03
Sortino ratio	-0.87
Sortino ratio (3Y)	0.82
Sortino ratio (5Y)	0.05
Volume	27.7K
Weekly RSI	39.6
YTD price change	-26.04%
YTD total return	-26.04%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46.5M
Shares change (QoQ)	-0.36%
Shares change (YoY)	7.3%
Shares held by insiders	12.66%
Shares held by institutions	70.64%
Shares outstanding	136.9M

Deeper analysis on BVMF/BIOM3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/BIOM3 report

Is a complete BVMF/BIOM3 research report available?

No complete published report is available for bvmf/BIOM3 (BVMF/BIOM3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/BIOM3 (BVMF/BIOM3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/BIOM3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/BIOM3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/BIOM3

Frequently asked questions